View Report Details The US Testosterone Market Report ----------------------------------------2016
View Report Details Executive Summary Testosterone industry is a prominent segment of the pharmaceutical industry. Testosterone is a steroid hormone which exerts effects on the males throughout life. Testosterone is significant for maintaining muscle bulk, adequate levels of red blood cells, bone growth, a sense of well-being, and sexual function. Low testosterone may result in decreased sex drive, erectile dysfunction, depression and loss of muscle mass. The testosterone level starts falling as the age of the person increases. Many other factors like injury or loss of testicles, chemotherapy, genetic abnormalities, chronic diseases and alcoholism may also result in low level of testosterone. Testosterone directly impacts the endocrine system, reproductive system, central nervous system and circulatory system of the body. Testosterone replacement therapy is used for treating the low level of testosterone. Testosterone therapy is available in several forms like gels, patches, injections and oral testosterone tablets. There are various benefits associated with the therapy like an increased sex drive, increase muscle mass and an improved bone mineral density. However, studies have shown that high risk of cardiovascular diseases and prostate cancer after the testosterone therapy due to which FDA has issued regulations. Due to FDA regulations the market has suffered in the US because of the warning given through labeling done on the products but the market is coming back on track with the introduction of more efficient products. Key products like Androgel, Axiron and Otrexup are performing well in the market and many are pending for approval. The key factors driving the growth of the market in the US are ageing population of the US, increasing healthcare expenditure per capita, decrease in fertility rate, increase in the US obese population and increased risk of developing hypogonadism. Some of the noteworthy trends and developments of this industry are introduction of oral testosterone pills and new drug, innovative gel technologies and testosterone therapy for women. However, the expansion of market can be affected by high risk of cardiovascular diseases, legal regulations and risk of prostate cancer. The report “The US Testosterone Market� provides an in-depth analysis of the US testosterone market along with product analysis. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry, Acrux, Antares Pharma, AbbVie and Endo International are being profiled.
Ageing population of the US, increase in obesity, increased risk of developing hypogonadism are the prominent factors affecting the growth of the US testosterone market.
US$ Billion
The US Testosterone Market by Value (2013-2018E)
As of …., the US testosterone market was recorded at US$.... billion, which is estimated to increase to US$...... billion by 2018. Around …. thousands prescriptions in the US were written in total in …, decreasing slightly from ….. thousands in 2014. It is estimated that ….. thousands prescriptions would be given by 2020. The US testosterone growth declined by …..% in 2015, which is likely to reach …..% by 2020. The growth rate of the testosterone prescriptions were at peak in 2013 with a …..%.
2015
2018E
Rxs (Thousand)
The US Testosterone Prescriptions by Volume (2012-2020E)
Y o Y P e r c e n ta g e G r o w th
2013
The US Testosterone Prescriptions Growth Rate (2013 – 2020E)
2013
2012
2013
2014
2015
2016E 2017E 2018E 2019E 2020E
2014
2015
2016E
2017E
2018E
2019E
2020E
Introduction of oral testosterone pills and testosterone therapy for women are the new trends in the US testosterone market.
T Rx (T h o u s a n d )
Injectable Testosterone Prescriptions by Volume (2012-2020E)
As of …., the total injectable testosterone prescriptions were …… thousands increasing from …… thousands in 2014 and is estimated to increase to ……. thousand by 2020. The total injectable prescription growth was recorded at …. in ….. and is expected to reach ….. by …... As of ….., the total topical testosterone prescriptions were …… thousands decreasing from …… thousands in 2014 and is estimated to reach …… thousand by 2020 as the market has started to regain consistency.
2013
2014
2015
2016E
2017E
2018E
2019E
2020E
Injectable Testosterone Prescriptions Growth Rate(2013-2020E)
Topical Testosterone Prescriptions by Volume (2012-2020E) T Rx (T housa nd)
Y o Y P e r c e n ta g e G r o w th
2012
2012
2013
2014
2015
2016E
2017E
2018E
2019E
2020E
2013
2014
2015
2016E 2017E 2018E 2019E 2020E
Y o Y P e r c e n ta g e G r o w th
High risk of cardiovascular diseases and risk of prostate cancer are the main threats to the industry. Topical Testosterone Prescription Growth Rate (2013-2020E)
The total topical prescription growth was recorded negative in 2015. The growth declined by …..%. The growth process is still in recovery and is expected to reach …… by 2020. The average level of testosterone at the age of … is …. ng/dl (nanogram/deciliter) which decreases to ….. in the age group of …. to .. years. The level goes on decreasing and reaches …… ng/dl at the age of 85.
2013
2014
2015
2016E
2017E
2018E
2019E
As of 2014, the total number of patients who opted for therapy was ….. million which is estimated to increase to …… million by 2015.
2020E
Decreasing Testosterone Level of Men with Age
Patients Opting for Therapy in the US by Volume (2010-2015E
ng/dl
Million
4 3 3 2 2 1 1 0 2010 Less Than 25 Years 35-44 years
55-64 years
75-84 years
2011
2012
2013
2014
2015E
Contact Us: View Report Details These are abridged and sanitized sample pages from the comprehensive report on the “ The US Testosterone Market ”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com